Home > Boards > US OTC > Medical - Healthcare > Medizone Intl. (MZEIQ)

Example of a " willing dupe " in denial .....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Tane61 Member Profile
 
Followed By 3
Posts 695
Boards Moderated 1
Alias Born 05/11/11
160x600 placeholder
Tane61   Saturday, 11/17/18 10:38:15 PM
Re: futurist7 post# 49116
Post # of 50293 
Example of a "willing dupe" in denial .....

Quote:
Thank you, Medizone had the patent and the technology to do this twenty years ago!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144958384


Quote:
The US granted Medizone patent for wound resolution "Method for the application of ozone/oxygen for the treatment of external pathogenic conditions" (09/126.504) is not flawed in any way. It has about 6 years of life to go. Human need for this technology would include the thousands of veterans with poorly healing war wounds, and those who fight ongoing battles with non-healing diabetic and vascular ulcers that too often end up with limb amputations.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=102679215


"There are none so blind as those who will not see" wink

----------

Application Of Ozone To External Body Surfaces:

Why would Medizone even consider implementing this patented (Sunnen, U.S. Pat. No. 6,073,627) ozone based technology when the inventor himself outlined, in a subsequent patent application (filed April 2005), shortcomings in respect of it's potential for effective application in the REAL WORLD?

http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1=20060241549.PGNR.

[0080] A previous invention (Sunnen, U.S. Pat. No. 6,073,627) included a transparent envelope with inserted sensors for ozone concentration, humidity, and patient temperature located within the treatment envelope, each relaying data to a display on the ozone generator panel.

[0081] Previous art such as U.S. Pat. No. 6,073,627 attempted to address this issue. This art described an ozone generator which delivered an ozone/oxygen mixture into a treatment envelope encasing the patient's lesion. The problem of delivering a precise ozone/oxygen mixture, however, was only partially solved by this art, based upon the following considerations:

[0082] 1. The ozone concentration within the treatment envelope was relayed to a readout gauge on the ozone generator, to be read by the clinical personnel. In order to maintain a constant ozone concentration over time and thus adhere to a precise treatment protocol, the personnel would be obliged not only to be present during the entire treatment process but also to adjust the generator's output in response to the fluctuations normally observed in intra-envelope ozone concentrations. [0083] It would therefore be desirable to have a delivery system with an automatic microprocessor-mediated feedback of intra-envelope ozone concentrations in order to counteract their fluctuations in a timely fashion.

[0084] 2. The temperature of the patient was monitored, but the temperature inside the treatment envelope was not. Intra-envelope ambient temperature is an integral part of the treatment protocol of external wounds with ozone/oxygen. Indeed, some dermatological lesions, such as frostbite, require higher therapeutic ambient temperatures while others do not. Furthermore, temperature itself has an influence upon ozone concentration, with lower temperatures associated with higher concentrations. [0085] It would therefore be desirable to provide a delivery system with a constant integration of ozone and temperature and an automatic microprocessor-mediated feedback of intra-envelope temperature to achieve temperature-to-ozone constancy.

[0086] 3. Intra-envelope humidity influences ozone concentration, with higher ozone output by the generator needed at higher humidity levels to maintain a constant ozone concentration. The therapy of dermatological conditions requires attention to the maintenance of intra-envelope humidity levels. Some lesions, such as wet gangrene, must be kept dry, while others need moisture. This invention may comprise an automatic microprocessor-mediated regulation of humidity levels to achieve constancy of the intra-envelope humidity milieu.

[0087] 4. The space within the treatment envelope can show significant regional variations and fluctuations in ozone concentration, temperature, and humidity, depending upon the placement of probes and the unavoidable presence of pockets of "dead space." This invention may comprise an intra-envelope fan to homogenize the ambient ozone/oxygen mixture so that probe readings will be accurate.

[0088] 5.Treatment envelopes in U.S. Pat. No. 6,073,627 were mere plastic bags. They required careful adjustment to anatomical parts so as to minimize unnecessary dead space, offer patient convenience, and avoid apposition of the envelope sheath to the patient's tissues. Described herein are improved envelopes having rigid or flexible supporting ribs or other supporting structures which address these needs.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=80605174

...Bulls Make Money, Bears Make Money, Pigs Get Slaughtered...
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist